Suppr超能文献

经支气管肺冷冻活检诊断的赖氨酸尿性蛋白不耐受症中的间质性肺疾病

Interstitial Lung Disease in Lysinuric Protein Intolerance Diagnosed by a Transbronchial Lung Cryobiopsy.

作者信息

Ono Mayumi, Abe Mitsuhiro, Saiki Ayae, Ogura Takashi, Takemura Tamiko, Suzuki Takuji

机构信息

Department of Respirology, Chiba University Hospital, Japan.

Department of Respirology, Kanagawa Cardiovascular and Respiratory Center, Japan.

出版信息

Intern Med. 2025 Aug 1;64(15):2375-2381. doi: 10.2169/internalmedicine.4074-24. Epub 2025 Feb 1.

Abstract

Lysinuric protein intolerance (LPI) is an autosomal recessive disease and pulmonary alveolar proteinosis is a respiratory complication. A Japanese man in his 30s, diagnosed with LPI in infancy, was diagnosed with interstitial lung disease (ILD) similar to fibrotic nonspecific interstitial pneumonia (f-NSIP) based on the findings of a transbronchial lung cryobiopsy. The pulmonary function deteriorated, and nintedanib was administered. Two years after initiation of nintedanib therapy, the patient was hospitalized for an acute exacerbation of interstitial pneumonia. Corticosteroid pulse therapy was administered twice, but the patient died approximately one month after emergency hospitalization. This is the first report of a patient with LPI diagnosed with ILD similar to f-NSIP using a cryobiopsy and who was treated with nintedanib.

摘要

赖氨酸尿性蛋白不耐受症(LPI)是一种常染色体隐性疾病,肺泡蛋白沉积症是其一种呼吸系统并发症。一名30多岁的日本男性在婴儿期被诊断为LPI,根据经支气管肺冷冻活检结果被诊断为与纤维化非特异性间质性肺炎(f-NSIP)相似的间质性肺疾病(ILD)。其肺功能恶化,遂给予尼达尼布治疗。尼达尼布治疗开始两年后,该患者因间质性肺炎急性加重住院。给予两次糖皮质激素冲击治疗,但患者在急诊住院后约一个月死亡。这是首例使用冷冻活检诊断为与f-NSIP相似的ILD并接受尼达尼布治疗的LPI患者报告。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bccc/12393915/502f40591c5c/1349-7235-64-15-2375-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验